Journal Guide

Autonomic & Autacoid Pharmacology is an international journal dealing with the interactions of drugs and related substances with the central and peripheral divisions of the autonomic nervous system and its effector organs and tissues. All aspects of basic experimental pharmacology in intact animals, isolated tissues and biochemical systems of tissue fractions are covered. This includes the effects of drugs acting on the autonomic nervous system and its effector organs in humans. The drugs under examination are primarily those with actions on the cardiovascular, respiratory and gastrointestinal systems of the body. The effector organs of the autonomic nervous system is interpreted in its widest sense to include substances affecting smooth and cardiac muscle in general. The scope of the journal has widened to include the pharmacology of autacoids including angiotensin, endothelin, kinins, prostaglandins, leukotrienes, opioids, cytokines, histamine and 5-hydroxytryptamine.

BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials.It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.

Bangladesh Journal of Pharmacology (Bangladesh J Pharmacol) is the peer-reviewed, open access official publication of the Bangladesh Pharmacological Society (BDPS). The printed version is published twice in a year (June and December). In the online version, papers are published immediately after acceptance. The current issue is incomplete.

Basic & Clinical Pharmacology and Toxicology is an independent journal, publishing original scientific research in all fields of toxicology, basic and clinical pharmacology. This includes experimental animal pharmacology and toxicology and molecular (-genetic), biochemical and cellular pharmacology and toxicology. It also includes all aspects of clinical pharmacology: pharmacokinetics, pharmacodynamics, therapeutic drug monitoring, drug/drug interactions, pharmacogenetics/-genomics, pharmacoepidemiology, pharmacovigilance, pharmacoeconomics, randomized controlled clinical trials and rational pharmacotherapy. For all compounds used in the studies, the chemical constitution and composition should be known, also for natural compounds.

Behavioural Pharmacology publishes original research which studies the ways in which behaviour is affected by any aspect of pharmacology. Topics include drug, chemical and hormonal effects on behaviour and resultant behaviour methods for the study of drug action. Speed of publication is a major feature of the journal!Published 8 times per yearWebsite: www.behaviouralpharm.com.

An essential resource for R&D professionals and clinicians with an interest in biologic therapies.BioDrugs covers the development and use of biotechnology-based pharmaceuticals and innovative technologies for the treatment of human disease.

Biochemical Pharmacology is devoted to publishing original work on the pharmacodynamics and pharmacokinetics of drugs and nontherapeutic xenobiotics. Its audience are scientists engaged in drug discovery and in identifying drug mechanisms of action. All areas of pharmacology are represented in the journal, including drug metabolism and kinetics. It is of particular value to those interested in anti-inflammatory drugs, cancer chemotherapy, neuropharmacology and cardiovascular pharmacology.While particular emphasis is placed on reporting findings that relate to the actions and metabolism of drugs and toxic substances at the biochemical and molecular levels, submissions in the areas of behavioral and physiological pharmacology and toxicology are also encouraged if they describe studies directed at defining mechanisms of action.Reports based on experiments conducted with mixtures, plant or animal extracts will not be considered for publication unless the chemical structures and concentrations of all substances are known and the compounds are obtained from commercial suppliers.The journal publishes the following types of reports:(1) Full-length Research Papers. These contain the results of original research on an issue of relevance to the field of pharmacology.(2) Commentaries. These are commissioned articles that provide the author's view on a selected topic of interest to pharmacologists.US National Institutes of Health (NIH) voluntary posting ("Public Access") policy Biochemical Pharmacology and Elsevier facilitate the author's response to the NIH Public Access Policy.Please bookmark this URL: http://www.elsevier.com/locate/biochempharmBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Biologicals provides a modern and multidisciplinary international forum for news, debate, and original research on all aspects of biologicals used in human and veterinary medicine. The journal publishes original papers, reviews, and letters relevant to the development, production, quality control, and standardization of biological derived from both novel and established biotechnologies. Special issues are produced to reflect topics of particular international interest and concern.Three types of papers are welcome: original research reports, short papers, and review articles. The journal will also publish comments and letters to the editor, book reviews, meeting reports and information on regulatory issues.Research Areas IncludeAreas relevant to biologicals for human and veterinary use such as:• Bacterial vaccines• Blood products• Cell biology• Cell culture technology• Cellular immunology• Cytokines and allied mediators• Diagnostics• Downstream processing• Gene transfer and expression• General bacterology• General virology, endogenous and adventitious viruses• Hormones• Immunochemistry• Molecular biology• Monoclonal antibodies• Parasitology• Prion and prion disease• Protein chemistry• Toxins• Toxoids• Viral vaccines

Biomedical Chromatography is devoted to the publication of original papers on the applications of chromatography and allied techniques in the biological and medical sciences. Research papers and review articles cover the methods and techniques relevant to the separation, identification and determination of substances in biochemistry, biotechnology, molecular biology, cell biology, clinical chemistry, pharmacology and related disciplines. These include the analysis of body fluids, cells and tissues, purification of biologically important compounds, pharmaco-kinetics and sequencing methods using HPLC, GC, HPLC-MS, TLC, paper chromatography, affinity chromatography, gel filtration, electrophoresis and related techniques. This journal, as well as reporting current research, also serves our community as a major resource for information on practical and instrumental methodology.

An international multidisciplinary journal with two objectives:- to create an interface between clinical and laboratory responses to drugs and to investigate critical approaches to different pathologies with regard to biological and clinical data,- to provide a niche for authors whose work is not directly defined by the review criteria of existing journals.Biomedicine and pharmacotherapy is one of the few journals at the forefront of fundamental and technical science, biological and medical disciplines, therapeutics and pathological description. General fields of interest include molecular and cell biology, genetic disease, immunology and immunoregulation and chemotherapy. Special emphasis is placed on studies of specific topics such as differentiation, pharmacology and toxicology, preclinical and clinical pharmacology, the effects of drugs on cell structural and functional elements, the mechanism of gene regulation in normal and pathological cells, the role of viruses and parasites and the therapy of the diseases they induce. Brief reports of meetings, symposia and conferences will also be considered for publication as well as announcements of scientific meetings or academic courses.

Biopharmaceutics & Drug Dispositionpublishes original review articles, short communications, and reports in biopharmaceutics, drug disposition, pharmacokinetics and pharmacodynamics, especially those that have a direct relation to the drug discovery/development and the therapeutic use of drugs. These includes: * animal and human pharmacological studies that focus on therapeutic response. pharmacodynamics, and toxicity related to plasma and tissue concentrations of drugs and their metabolites, * in vitro and in vivo drug absorption, distribution, metabolism, transport, and excretion studies that facilitate investigations related to the use of drugs in man * studies on membrane transport and enzymes, including their regulation and the impact of pharmacogenomics on drug absorption and disposition, * simulation and modeling in drug discovery and development * theoretical treatises * includes themed issues and reviews and exclude manuscripts on * bioavailability studies reporting only on simple PK parameters such as Cmax, tmax and t1/2 without mechanistic interpretation * analytical methods Reports must contain current citation of the literature and convey new information. Biopharmaceutics & Drug Disposition is one of the top accessed and cited journals in the field, as a result of the high quality papers published in the journal, and is marketed by Wiley Blackwell across the world.

Reports on all aspects of drug action in humansOriginal papers. reviews. editorials. letters. book reviewsNorth American. European. Australasian EditorsSpecial supplements on new drugsOpen-access after 12 monthsOnline submission through ScholarOne Manuscripts Published on behalf of the British Pharmacological Society Aims and Scope Published on behalf of the British Pharmacological Society. theBritish Journal of Clinical Pharmacologycontains papers and reports on all aspects of drug action in humans: invited review articles. original papers. short communications and correspondence. The Journal enjoys a wide readership. bridging the gap between the medical profession. clinical research and the pharmaceutical industry. Proceedings of the meetings of the Clinical Section of the British Pharmacological Society are published in abstract form. and supplements containing information on new methods. new drugs and new approaches to treatment are supplied free of charge. All editorials now available to access free online. Clickhere to access now! Readership The journal contains research and review articles on all aspects of drug action in humans. together with abstracts of clinical proceedings of the Society. The journal is recognized as one of the leading publications in its field. The readership consists of clinical pharmacologists in academic and NHS posts. pharmacologists. pharmacists. physicians as well as scientists in the pharmaceutical industry. The readership reflects the journal"s role as a bridge between the medical professions. clinical research and the pharmaceutical industry.

2009 Impact Factor: 5.204* BJPis the highest ranked general pharmacology research journal. now ranked 19th in the ISI Pharmacology and Pharmacy category* * Thomson Reuters Science Citation Index 2009 Aims and Scope TheBritish Journal of Pharmacology(BJP) is a broad-based journal giving leading international coverage of all aspects of experimental pharmacology. Its scope includes: Anti-infective drugs Biopharmaceuticals Cancer pharmacology Cardiovascular pharmacology Drug discovery Drug safety and toxicology Endocrine and metabolic pharmacology Gastrointestinal pharmacology Genitourinary and renal pharmacology Immunopharmacology and Inflammation Molecular and cellular mechanisms Neuropharmacology Pharmacokinetics and drug metabolism Respiratory system pharmacology Methods and techniques Social impact of pharmacology Readership Pharmacologists; toxicologists; pharmaceutical researchers; medicinal chemists; molecular biologists; physiologists; neuroscientists; target discovery and drug discovery researchers. pharmacists; clinicians. Keywords British Journal of Pharmacology. BJP. journal. pharmacology. pharmacological. drugs. therapeutics. medicinal chemistry. pharmaceutical medicine. experimental pharmacology. translational research. biopharmaceuticals. drug discovery. drug safety. pharmacokinetics and drug metabolism. toxicology. neuropharmacology. cardiovascular pharmacology. respiratory pharmacology. immunopharmacology. cancer. endocrine pharmacology. GRAC. receptors. channels. transporters. G-protein coupled receptors. antagonist. agonist. drug targets. target discovery. drug design. pharma. pharmaceutical research. British Pharmacological Society.

The Bulletin of Mathematical Biology is devoted to research at the junction of computational, theoretical and experimental biology. Articles offer a combination of theory and experiment, documenting theoretical advances with clear exposition of how they further biological understanding. Its aim is to be of major interest to theorists and experimental biologists alike.The Bulletin of mathematical biology also invites submissions of review articles which offer an in-depth treatment of an emerging research area, or a significant recent development, in the general area of computational, theoretical and mathematical biology. Those interested in writing such a review article should contact James Sneyd at sneyd@math.auckland.ac.nz This is the official journal of the Society for Mathematical Biology.

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.

Published since 1929, this monthly journal reports current research in all aspects of physiology, nutrition, pharmacology, and toxicology, contributed by recognized experts and scientists. It publishes symposium reviews and award lectures and occasionally dedicates entire issues or portions of issues to subjects of special interest to its international readership. The journal periodically publishes a “Made In Canada” special section that features invited review articles from internationally recognized scientists who have received some of their training in Canada.

Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.